Company: TALK
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001140361-25-016714
Chunk: 12

Company: Talkspace, Inc.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 12
---
 for the election as Directors the nominees whose names and biographies appear below. All of the persons whose names and biographies appear below are currently serving as our directors. In the event any of the nominees should become unable to serve or for good cause will not serve as a director, it is intended that votes will be cast for a substitute nominee designated by the Board or the Board may elect to reduce its size. The Board has no reason to believe that the nominees named below will be unable to serve if elected. Each of the nominees has consented to being named in this proxy statement and to serve if elected. VOTE REQUIRED The proposal regarding the election of directors requires the approval of a plurality of the votes cast. This means that the three nominees receiving the highest number of affirmative “FOR” votes will be elected as Directors. Votes withheld and broker non-votes will have no effect on the outcome of the vote on this proposal. RECOMMENDATION OF THE BOARD OF DIRECTORS

| The Board of Directors unanimously recommends a vote FOR the election of the below Director nominees. |

8

NOMINEES FOR DIRECTORS (CURRENT TERM TO EXPIRE AT THE 2025 ANNUAL MEETING) The nominees for election to the Board as Class I Directors are as follows:

| Name         |     | Age |     |    Served as a 
 Director Since |     | Positions with Talkspace             |
| Jon Cohen    |     |  71 |     |           2022 |     | Chief Executive Officer and Director |
| Erez Shachar |     |  61 |     |           2021 |     | Director                             |
| Madhu Pawar  |     |  45 |     |           2021 |     | Director                             |

The principal occupations and business experience, for at least the past five years, of each Class I Director are as follows:

| DR. JON COHEN, M.D. |     | Age 71 |

Dr. Cohen has served as Talkspace's Chief Executive Officer since November 2022, and has served as Director since September 2022. Dr. Cohen has served as Executive Chairman of BioReference Laboratories and Senior Vice President of OPKO Health (NASDAQ: OPK) from 2019 until August 2022. From 2009 to 2018, Dr. Cohen served as an executive officer of Quest Diagnostics. Prior to that he served as Senior Advisor to New York Governor David A. Paterson, where he was responsible